Kyowa Kirin International

About Kyowa Kirin International

Kyowa Kirin International is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative medicines. With a strong focus on improving the quality of life for patients, the company operates in various therapeutic areas including oncology, nephrology, and immunology.

Founded on the principles of science and compassion, Kyowa Kirin International strives to address unmet medical needs through cutting-edge research and development. The company’s commitment to innovation is reflected in its robust pipeline of novel therapies that aim to provide effective solutions for complex diseases.

Kyowa Kirin International places a high value on collaboration, working closely with healthcare professionals, researchers, and patient advocacy groups to ensure that their products meet the highest standards of safety and efficacy. The company is also dedicated to sustainability and ethical practices, ensuring that its operations have a positive impact on society and the environment.

With headquarters in the UK, Kyowa Kirin International is part of a larger global network that spans multiple countries, allowing it to leverage diverse expertise and resources. The company is committed to fostering a culture of excellence and continuous improvement, empowering its employees to contribute to the mission of enhancing patient outcomes.

In summary, Kyowa Kirin International is at the forefront of biopharmaceutical innovation, driven by a passion for science and a commitment to patient care. Through its dedication to research and collaboration, the company aims to transform the landscape of healthcare and make a meaningful difference in the lives of patients worldwide.